SymbiCom R&D IVS: Financial statements 2019
CVR: 38362623
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
SymbiCom R&D IVS (CVR 38362623) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 100. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 100
- Total Assets
- DKK 100
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of July 1, 2019, Torben Christensen is registered as adm. dir. of SymbiCom R&D IVS.
As of June 19, 2019, Jacob Kuno Martinsen has stepped down as director of SymbiCom R&D IVS.
SymbiCom R&D IVS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK 0.
About SymbiCom R&D IVS
SymbiCom R&D IVS was a Danish company of the type Iværksætterselskab based in Vipperød, founded in 2017. The company has been dissolved on 28 September 2021. The company was registered under the industry Genbrug af sorterede materialer. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 100.
